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The purpose of this study was to examine the effect of regular exercise training on insulin sensitivity in adults with type 2 diabe-
tes mellitus (T2DM) using the pooled data available from randomised controlled trials. In addition, we sought to determine 
whether short-term periods of physical inactivity diminish the exercise-induced improvement in insulin sensitivity. Eligible tri-
als included exercise interventions that involved ≥3 exercise sessions, and reported a dynamic measurement of insulin sensitivi-
ty. There was a significant pooled effect size (ES) for the effect of exercise on insulin sensitivity (ES, –0.588; 95% confidence in-
terval [CI], –0.816 to –0.359; P<0.001). Of the 14 studies included for meta-analyses, nine studies reported the time of data col-
lection from the last exercise bout. There was a significant improvement in insulin sensitivity in favour of exercise versus control 
between 48 and 72 hours after exercise (ES, –0.702; 95% CI, –1.392 to –0.012; P=0.046); and this persisted when insulin sensi-
tivity was measured more than 72 hours after the last exercise session (ES, –0.890; 95% CI, –1.675 to –0.105; P=0.026). Regular 
exercise has a significant benefit on insulin sensitivity in adults with T2DM and this may persist beyond 72 hours after the last 
exercise session.
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INTRODUCTION
Exercise is an integral component of the lifestyle management 
of type 2 diabetes mellitus (T2DM). Current exercise guide-
lines recommend that adults with T2DM should undertake 
aerobic-type exercise at moderate and/or vigorous intensity 
on 3 to 5 days per week, ideally combined with regular vigor-
ous progressive resistance training (PRT) [1,2]. Meta-analyses 
have demonstrated that this dose of regular exercise is effec-
tive in improving glycaemic control as measured by change in 
glycosylated hemoglobin (HbA1c) in diabetic cohorts [3].
Insulin resistance itself has been shown to significantly in-
crease the incidence and prevalence of cardiovascular disease 
(CVD) in individuals with T2DM [4]. For instance, in a longi-
tudinal study which monitored CVD in individuals with 
T2DM, each unit increase in homeostasis model of insulin re-
sistance was associated with a 31% greater risk of CVD (odds 
ratio [OR], 1.48), and a 56% elevated risk of CVD in individu-
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als who were followed-up at 52 months (OR, 2.24) [4]. In a 
study which examined insulin-stimulated glycaemic control 
in healthy individuals over a 4 to 11 years period, greater insu-
lin resistance was associated with an increased incidence of 
age-related chronic conditions including hypertension, coro-
nary heart disease, stroke, and cancer [5]. Thus insulin resis-
tance itself has a significant detrimental impact on health and 
the development of chronic disease.
The role of chronic versus acute factors in accounting for 
the insulin sensitizing benefit of exercise is unclear, and this 
has implications for the use of exercise in the management of 
T2DM. For instance, exercise increases insulin-mediated glu-
cose transporter type 4 (GLUT4) translocation to the sarco-
lemma and subsequent glucose uptake, which may reflect a 
transient elevation as a consequence of the “last bout” [6]. The 
underlying increase in GLUT4 transcription and expression 
of GLUT4 mRNA has been shown to persist for 3 to 24 hours 
after exercise [7,8]. In this way, regular exercise translates into 
a steady-state increase of GLUT4 protein expression, and sub-
sequent improvement in glucose control over time [7]. Simi-
larly, enhanced whole-body insulin sensitivity has been 
shown to occur in the hours immediately following exercise, 
and evidence from a limited number of studies using hyperin-
sulinaemic-euglycaemic clamp and oral glucose tolerance test 
(OGTT) suggests that this may persist for up to 24 to 72 hours 
after the last bout [1,9,10]. Current guidelines reflect this con-
cept of a transient benefit that may be “lost,” by recommend-
ing that consecutive days of physical inactivity should be 
avoided [1,2].
However, while there is evidence that supports the use of 
exercise as a management strategy to control HbA1c and fast-
ing insulin in T2DM, these static measurements do not di-
rectly evaluate the underlying insulin sensitivity [11]. To our 
knowledge, there is limited data concerning the effect of regu-
lar exercise on dynamically measured insulin sensitivity in 
people with T2DM [1,12], and no systematic examination and 
meta-analysis of the pooled evidence has been undertaken.
The purpose of this study was to examine the effect of regu-
lar exercise training on insulin sensitivity in people with 
T2DM using the collective data available from randomised 
controlled trials (RCTs). In addition, we sought to determine 
whether short-term (days) periods of physical inactivity di-
minish the exercise-induced improvement in insulin sensitiv-
ity in adults with T2DM. 
METHODS
Design
Electronic database searches were performed in AMED, 
MEDLINE, SPORTDiscus, CINAHL, EMBASE, and Web of 
Science Core Collections from earliest record to December 
2014. The search strategy combined terms covering the areas 
of aerobic exercise training, strength training, and insulin 
sensitivity. Specifically, the database searches were performed 
using the keywords: strength training, weight training, resis-
tance training, progressive training, progressive resistance, 
weight lifting; or aerobic exercise, endurance exercise, aerobic 
training, endurance training, cardio training, exercise, physi-
cal endurance, physical exertion; and insulin sensitivity, insu-
lin resistance, tolerance test, OGTT, ITT, IVGTT, MTT, IST, 
clamp. The latter terms refer to oral glucose tolerance test 
(OGTT), insulin tolerance test (ITT), intravenous glucose tol-
erance test (IVGTT), meal tolerance test (MTT), and insulin 
secretion test (IST), respectively. 
Reference lists of all retrieved papers were manually searched 
for potentially eligible papers. RCTs published in all languages 
were included while non-RCTs, uncontrolled trials, cross-sec-
tional studies, and theses were excluded from review.
Interventions
Studies were included if the exercise training intervention in-
volved three or more exercise sessions. Trials where partici-
pants were randomised to an intervention involving either 
aerobic exercise (i.e., continuous, intermittent, or high inten-
sity interval training [HIIT]) (aerobic exercise training [AEx]) 
or PRT, or combined (AEx+PRT), were included. Studies in-
volving dietary interventions were included only if the diet 
was the same in the exercise and control groups.
Participants
Trials that were completed with individuals with T2DM, who 
were of 18 years or older, were included in the review. 
Outcome measures
Trials that were eligible for the review reported measurements 
that assessed dynamic insulin sensitivity. Measures that were 
considered as dynamic assessments of insulin sensitivity eval-
uated the glucose response to insulin/glucose stimulation. To 
be eligible for review, studies needed to report the change in 
glucose based on the dynamic insulin sensitivity assessment. 
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Clamps: euglycaemic clamp
Glucose levels are clamped and titrated at a predetermined 
level, in conjunction with continuous insulin infusion at a 
fixed rate. It is considered the gold standard measure for insu-
lin resistance [13]. Blood concentrations are measured every 3 
to 5 minutes. Insulin resistance is determined by the rate/
amount of glucose that is necessary to maintain the predeter-
mined blood glucose concentration [13]. 
Clamps: hyperglycaemic clamp
This measurement also involves clamping glucose at a prede-
termined hyperglycaemic level by intravenously infusing glu-
cose into the blood. Insulin sensitivity is calculated by divid-
ing the glucose infusion rate needed to maintain a hypergly-
caemic state by the mean insulin concentration over the last 
20 to 30 minutes of the clamp [13]. 
Insulin infusion sensitivity tests 
Insulin infusion testing is similar to clamping methods, but 
without the intensive blood sampling that is used in the 
clamping methodology. Somatostatin may also be infused in 
these tests to suppress endogenous insulin secretion, gluca-
gon, growth hormone, and gluconeogenesis. Glucose, insulin, 
and somatostatin are infused continuously for 150 to 180 
minutes at predetermined constant rates. The steady state 
plasma glucose, the mean glucose over the last 30 minutes of 
the test, reflects insulin sensitivity/resistance [13]. 
Insulin tolerance test 
Insulin resistance in this assessment is estimated by the rate of 
decline in glucose levels following an intravenous bolus of in-
sulin. Blood samples are taken every 2 minutes for 15 minutes 
and reflect the suppression of hepatic glucose output and 
stimulation of peripheral glucose uptake. The rate, expressed 
as a percentage decline in glucose per minute, is calculated by 
the rate of decline of the log transformed glucose concentra-
tions by linear regression. This calculation reflects insulin sen-
sitivity [13]. 
Oral glucose tolerance test
OGTT assesses insulin resistance and secretion by sampling 
the plasma glucose concentrations typically every 15 to 30 
minutes for 2 hours following a 75 g oral glucose load [13]. 
The individual must be in a fasted state (8 to 14 hours) prior 
to completing the test. There are several surrogate markers of 
insulin resistance that can be obtained from an OGTT, such 
as the Matsuda index, Gutt index, Stumvoll index, Avignon 
index, and oral glucose sensitivity index [11]. The OGTT has 
been shown to correlate with the hyperglycaemic clamp as a 
measure of insulin resistance [14]. 
Selection of studies
After eliminating duplications the search results were screened 
by two investigators (KLW, DAH) against the eligibility crite-
ria, and those references that could not be eliminated by title 
or abstract were retrieved and independently reviewed by two 
reviewers (KLW, DAH) in an unblinded manner. Disagree-
ments were resolved by discussion or by a third and forth re-
searcher (MKB, NAJ). In cases where journal articles con-
tained insufficient information, attempts were made to con-
tact authors to obtain missing details (KLW, DAH). 
Data extraction and calculations
Data relating to participant characteristics (age, sex, body 
mass index [BMI]), exercise intervention (mode of exercise, 
exercise frequency, intensity, duration, and intervention dura-
tion) and measures of insulin sensitivity were extracted inde-
pendently by two researchers (KLW, DAH), with disagree-
ments resolved by discussion or by two researchers (MKB, 
NAJ). 
Assessment of methodological quality
Two researchers (KLW, DAH) assessed the methodological 
quality of the included studies (in a blinded manner) using a 
modified Downs and Black [15] checklist recommended by 
the Cochrane Handbook for Systematic Reviews of Interven-
tions [16]. The tool consists of 27 items rated as ‘no, 0; unable 
to determine, 0; and yes, 1’ and includes criteria such as: clear 
description of the aims, interventions, outcome measure-
ments and participants, representativeness of participant 
groups, appropriateness of statistical analyses, and correct re-
porting. The checklist was slightly modified so that the final 
item (number 27) relating to statistical power was consistent 
with the scoring used for the other items (i.e., from the origi-
nal score of 0 to 5 to ‘no, 0; unable to determine, 0; and yes, 1’). 
Additionally, two extra criteria were added to the checklist; 
these were exercise supervision, and monitoring the adher-
ence of participants during the intervention (Supplementary 
Table 1). 
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Analyses
The within trial standardised mean difference, or effect size 
(ES), and 95% confidence intervals (CIs) were calculated. Be-
tween-study variability was examined using the I2 measure of 
inconsistency. This statistic, expressed as a percentage between 
0 to 100, provides a measure of how much of the variability be-
tween studies is due to heterogeneity rather than chance. Pub-
lication bias was assessed by using Egger’s test. Subsequently 
this resulted in two studies [17,18] being excluded from the 
analyses due to unrealistic large positive effects.
Meta-analyses
Pooled estimates of the effect of exercise on insulin sensitivity, 
using ES, were obtained using a random-effects model. Sub-
analyses were also undertaken to examine the effect of: (1) ex-
ercise versus control on insulin sensitivity measured <48 
hours after the last exercise bout; (2) exercise versus control 
on insulin sensitivity measured 48 to 72 hours after the last 
exercise bout and; and (3) exercise versus control on insulin 
sensitivity measured >72 hours after the last exercise bout. All 
analyses were conducted using Comprehensive Meta-Analysis 
version 2 (Biostat Inc., Englewood, NJ, USA).
RESULTS
Identification and selection of studies
The original search yielded 27,041 studies. One study was 
found from the reference lists of the manuscripts retrieved. 
After removal of duplicates and elimination of papers based 
on the eligibility criteria, 16 studies remained (Supplementary 
Fig. 1). 
Cohort characteristics
Participant characteristics for included studies are shown in 
Table 1. Of the studies examined, the majority were conducted 
in previously inactive T2DM populations, predominantly 
with male cohorts. When combined, 479 individuals (193 
male; 166 female; 120 not reported) participated in the trials. 
One study exclusively recruited female participants [19], two 
studies exclusively recruited male participants [20,21], nine 
studies recruited both males and females [17,18,22-28], and 
sex was not reported in four studies [29-32]. The reported 
mean age of participants ranged from 45.0 to 69.5 years. Based 
on BMI classification [33], seven studies had participants who 
were classified on average as overweight [17,18,21-25], six as 
obese class I [19,26-30], and two as obese class II [20,32]. 
There was one study that did not report mean BMI [31].
Exercise characteristics
Exercise intervention characteristics are displayed in Table 2. 
Walking was the most common mode of AEx, while exercises 
with weight machines were most commonly used for PRT. For 
the AEx training interventions, 10 studies used continuous 
training [17,18,21,24,27-32], two studies used a combination 
of continuous and HIIT [21,30], and one study compared 
continuous training with HIIT [24]. AEx training was most 
commonly performed 3 days per week [17,21,28-30] with ses-
sions lasting 25 to 60 minutes for 1 to 26 weeks. Aerobic exer-
cise intensity, expressed as a percentage of maximal heart rate 
(HRmax), percentage of heart rate reserve, percentage or peak 
of maximal rate of oxygen consumption, or percentage of peak 
energy expenditure, ranged from 35% to 95% [2,17-19,21,24-
26,28,29,31]. PRT was combined with AEx training in five 
studies [19,22,23,25,26], whilst PRT was performed alone in 
two studies [20,22]. PRT was most commonly performed 3 
days per week, involving two sets per exercise for eight to 12 
repetitions, for 10 to 24 weeks. The intensity of PRT, quanti-
fied as a percentage of one-repetition maximum (1 RM) in 
three studies, ranged between 50% to 70% 1 RM [22,25,26]. 
One study prescribed intensity as 10 to 15 of RM [20]. 
Four studies included a dietary or supplement intervention 
in conjunction with exercise and control [17,18,30,32]. Ome-
ga 3 polyunsaturated fatty acid supplementation as fish meal 
was implemented in one of the studies [17], and branched 
chain amino acid supplementation in another study [30]. Two 
studies used diet interventions aimed at energy restriction of 
either 27.9 kcal/kg of ideal body weight [18] or body weight 
reduction (1 kg/week) [32]. In all of these studies, the same 
dietary intervention was given to both exercise and control 
groups.
Methodological quality
All included studies specified their hypotheses, main out-
comes, participant characteristics, interventions, main find-
ings, variability estimates, representative participants, statisti-
cal tests, and accuracy of measures (Supplementary Table 1). 
The majority of studies provided supervision for the interven-
tion groups [17,19,20,24-30,32] and reported adherence to 
exercise training during the intervention [17,19,20,22,23,25-
30,32]. There were eight studies that did not report adverse 
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Table 1. Participant characteristics      
Author Subject, n Male sex, % Age, yr BMI Medication, n
Baldi et al. 
(2003) [20]a
C, 9
PRT, 9
100 C, 50.1±3.9
PRT, 46.5±6.3
C, 36.4±9.3
PRT, 34.3±9.6
Biguanides, 11
Sulfonylureas, 7
Boudou et al. 
(2003) [21]
C, 8
AEx, 8
100 C, 47.9±8.4
AEx, 42.9±5.2
C, 30.9±5.2
AEx, 28.3±3.9
C: 
   Metformin, 4
    Metformin and gliclazide or 
glibenclamide, 1
AEx: 
    Metformin, 2
    Metformin and gliclazide or 
glibenclamide, 4
Cuff et al.  
(2003) [19]a
C, 9
AEx, 9
AEx+PRT, 10
0 C, 60.0±8.7
AEx, 59.4±5.7 
AEx+PRT, 63.4±7.0
C, 36.7±6.0
AEx, 32.5±4.2 
AEx+PRT, 33.3±4.7 
Oral hypoglycaemics
Dunstan et al. 
(1997) [17]
C, 12
AEx, 11
F, 12
AEx+F, 14
C, 75
AEx, 72.7
F, 83.3
AEx+F, 71.4
C, 53.0±7.0
AEx, 52.3±8.3
F, 54.1±8.2
AEx+F, 52.6±7.2
C, 29.7±4.3
AEx, 29.1±2.4
F, 29.8±4.4
AEx+F, 29.9±3.0
Antidiabetic and antihyperten-
sive medication
Dunstan et al. 
(1998) [22]a
C, 10
PRT, 11
C, 50
PRT, 72.7
C, 51.1±7.0
PRT, 50.3±6.6
C, 30.1±3.5
PRT, 28.3±2.7
Sulfonylureas, 4
Biguanides, 5 
Sulfonylureas+biguanides, 10
Karstoft et al. 
(2013) [24]a
C, 8
AEx,
   Continuous, 12
   Intermittent, 12
C, 62.5
AEx, 
   Continuous, 66.7 
   Intermittent, 58.3
C, 57.1±8.5
AEx, 
   Continuous, 60.8±7.6 
   Intermittent, 57.5±8.3
C, 29.7±5.4
AEx, 
   Continuous, 29.9±5.5 
   Intermittent, 29.0±4.5
Antidiabetic and antihyperten-
sive medication (abstained 
for 5 days prior to pre-/post- 
testing)
Ligtenberg et al. 
(1997) [28]
C, 28
AEx, 30
C, 35.7
AEx, 33.3
C, 61.0±5.0
AEx, 63.0±5.0
C, 31.2±3.3
AEx, 30.8±4.0
Oral hypoglycaemics and  
insulin
Middlebrooke  
et al. (2006) [29]
C, 30
AEx, 22
At initial recruit-
ment overall, 54.2
C, 64.6±6.8
AEx, 61.8±7.7
C, 29.9±5.4
AEx, 31.8±4.5
Oral hypoglycaemics
Mourier et al. 
(1997) [30]a
C, 11
AEx, 10
At initial recruit-
ment overall, 83.3
C, 46.0±10.0
AEx, 45.0±6.3
C, 30.1±5.3
AEx, 30.4±2.5
Metformin, 14;
Sulfonylurea, 3
Okada et al. 
(2010) [23]
C, 17 
AEx+PRT, 21
C, 64.7
AEx, 47.6
C, 64.5±5.9
AEx, 61.9±8.6
C, 24.5±2.9
AEx, 25.7±3.2
Study reported both groups  
received comparable medical 
intervention after registration 
for 3 months
Ronnemaa et al. 
(1986) [31]
C, 12
AEx, 13
At recruitment, 
66.7
At recruitment overall, 
52.5 (NR)
NR Sulfonylureas, 18 
Metformin+sulfonylureas, 10
Tamura et al. 
(2005) [18]a
D, 7
AEx+D, 7
D, 57.1
AEx+D, 42.8
D, 55.0±12.7
AEx+D, 46.3±7.4
D, 27.4±8.5
AEx+D, 27.1±7.7
D: 
   Sulfonylureas, 3 
   Metformin+sulfonylureas, 2
   α-Glucosidase inhibitor, 2
D+AEx: 
   Sulfonylureas, 3 
   Metformin+sulfonylureas, 3
   α-Glucosidase inhibitor, 1
Tan et al.  
(2012) [25]
C, 10 
AEx+PRT, 15
At recruitment: 
   C, 45.5
   AEx+PRT, 44.4
C, 64.8±6.8
AEx+PRT, 65.9±4.2
C, 25.8±2.5
AEx+PRT, 25.2±2.5
Oral hypoglycaemics
(Continued to the next page)
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Table 1. Continued 
Author Subject, n Male sex, % Age, yr BMI Medication, n
Tessier et al. 
(2000) [26]
C, 20 
AEx+PRT, 19
C, 55.0
AEx+PRT, 63.2
C, 69.5±5.1
AEx+PRT, 69.3±4.2
C, 29.4±3.7
AEx+PRT, 30.7±5.4
Glyburide: 
   C, 12
   AEx+PRT, 10
Metformin: 
   C, 15
   AEx, 14
Wing et al. 
(1988) [32]
Include study 1: 
   P+D, 12
   AEx+D, 10
At recruitment: 
   Study 1, 16.0
Study 1: 
   P+D, 52.5±8.9
   AEx+D, 56.2±7.5
Study 1: 
   D+P, 37.2±1.8
   AEx+D, 39.5±1.9
Study 1: 
   P+D, oral hypogylcaemics, 6 
   AEx+D, oral hypoglycaemics, 
6
Winnick et al. 
(2008) [27]
D, 9
AEx+D, 9
D, 33.3
AEx+D, 22.2
D, 50.9±3.2
AEx+D, 48.4±8.4
D, 32.0±5.3
AEx+D, 34.9±3.1
At the outset of the study, all 
participants discontinued  
diabetic related medication
Values are presented as mean±standard deviation.     
BMI, body mass index; C, control; PRT, progressive resistance training; AEx, aerobic exercise training; F, fish meal; NR, not reported; D, diet; 
P, placebo.      
aConverted from standard error of mean to standard deviation.
Table 2. Exercise intervention details      
Author Mode Nutritional intervention Frequency Intensity
Session 
duration
Intervention 
duration
Baldi et al. 
(2003) [20]a 
C: non exercising control
PRT: circuit targeting 
major muscle groups of 
the upper and lower 
body
Nil C: NA
PRT: 3/7  
(supervised)
C: NA
PRT: 10 RM upper 
body, 15 RM 
lower body exer-
cises 
C: NA
PRT: progressing from 
one to three sessions/
week;  multiple sets of 
12 reps for 10 exercises 
(60 seconds recovery 
between sets)
10 weeks
Boudou et al. 
(2003) [21]
C: sham intervention 
(cycle ergometer)
AEx (continuous and 
HIIT): NR
Nil C: 1/7 (super-
vised)
AEx: 2/7+1/7,  
respectively  
(supervised)
C: 30 W (60 rpm)
AEx: 
   Continuous: 
75% VO2peak
   HIIT: 50%–85% 
VO2peak
C: 20 minutes
AEx:
   Continuous: 45 min-
utes
   HIIT: 5×2 minutes at 
85% VO2peak, 3 min-
utes at 50% VO2peak 
between exercises
8 weeks
Cuff et al. 
(2003) [19]a
C: usual care
AEx (continuous): tread-
mill, stationary cycle 
ergometers, recumbent 
steppers, elliptical 
trainers, and rower  
ergometer
AEx (continuous)+PRT: 
   AEx–treadmills: sta-
tionary cycle ergome-
ters, recumbent step-
pers, elliptical train-
ers, rowing machines
Nil C: usual care
AEx: 3/7  
(supervised)
AEx+PRT: 3/7 
(supervised)
C: NA
AEx: 60%–75% 
HRR
AEx+PRT: 
   AEx: 60%–75% 
HRR
   PRT: 2×12 reps
C: NA
AEx: 75 minutes
AEx+PRT: 75 minutes
16 weeks
(Continued to the next page)
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Table 2. Continued 
Author Mode Nutritional intervention Frequency Intensity
Session 
duration
Intervention 
duration
   AEx–PRT: stack weight 
equipment: leg press, 
leg curl, hip exten-
sion, chest press, and 
latissimus pulldown
Dunstan et al. 
(1997) [17]
C: sham exercise (cycle 
ergometer and stretch-
es)
AEx (continuous): cycle 
ergometer
F: sham exercise. Cycle 
ergometer and stretch-
es
AEx (continuous)+F:  
cycle ergometer
All participants 
were advised to 
reduce their  
sodium intake 
<100 mmol/
day
Fish intake 
groups were  
instructed to 
include one fish 
meal per day
C: 3/7 (super-
vised)
AEx: 3/7 (super-
vised)
F: 3/7 (supervised)
AEx+F: 3/7  
(supervised)
C: Nil
AEx: 
Week 1: 50%–
55% VO2peak
Week 2–8: 55%–
65% VO2peak
F: no workload
AEx+F: 
   Week 1: 50%–
55% VO2peak
   Week 2–8: 55%–
65% VO2peak
C: 10 minutes cycling; 
30 minutes of stretch-
ing
AEx: 40 minutes
F: 10 minutes cycling; 
30 minutes of stretch-
ing
AEx+F: 40 minutes
8 weeks
Dunstan et al. 
(1998) [22]a
C: non-exercising
PRT: circuit including 
leg extension, bench 
press, leg curl, bicep 
curls, overhead press, 
seated row, forearm ex-
tension, and abdominal 
curls 
Nil C: NA
PRT: 3/7 (supervi-
sion NR)
C: NA
PRT: 50%–55% 1 
RM
C: NA
PRT: 60 minutes
8 weeks
Karstoft et al. 
(2013) [24]a
C: NR
AEx: 
   Continuous: walking
   Intermittent: walking
Nil C: NA
AEx: 
   Continuous: 5/7 
(unsupervised)
   Intermittent: 5/7 
(unsupervised) 
C: NA
AEx: 
   Continuous: 
55% of peak 
energy-expen-
diture rate
   Intermittent: 
55%–70% of 
peak energy-
expenditure 
rate
C: NA
AEx: 
   Continuous: 60 min-
utes
   Intermittent: 60 min-
utes (3 minutes at 
70% followed by 3 
minutes at 55% of 
peak energy-expen-
diture rate)
4 months
Ligtenberg  
et al. (1997) 
[28]
C: education program 
AEx (continuous): 
   Phase 1: cycle ergometer, 
swimming, treadmill, 
and rower ergometer
   Phase 2: exercise at home 
based on personalised 
training advice (with 
contact from investiga-
tors)
   Phase 3: exercise at home 
without contact from 
investigators
Nil C: NR
AEx: 
Phase 1: 3/7  
supervised for  
6 weeks
Phase 2: phone 
calls 1/14 for 6 
weeks. NR fre-
quency of exer-
cise
Phase 3: NR
C: NR
AEx: 
Phase 1: 60%–
80% VO2peak
Phase 2: NR
Phase 3: NR
C: NR
AEx: 
Phase 1: 60 minutes 
Phase 2: NR
Phase 3: NR
26 weeks
(Continued to the next page)
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Author Mode Nutritional intervention Frequency Intensity
Session 
duration
Intervention 
duration
Middle-
brooke et al. 
(2006) [29]
C: standard care
AEx (continuous): NR
Nil C: NA
AEx: 3/7 (2/7 su-
pervised; 1/7 
unsupervised)
C: NA
AEx: 70%–80% 
HRmax
C: NA
AEx: 50–60 minutes
6 months
Mourier et al. 
(1997) [30]a 
C: NR
AEx (continuous and 
HIIT): cycle ergometer
Branched chain 
amino acid sup-
plementation 
(46% leucine, 
24% isoleucine, 
30% valine)
Supplementation 
did not effect 
metabolic  
parameters
C: NA
AEx: 2/7 continu-
ous+1/7 HIIT
C: NA
AEx: 
Continuous: 
75% VO2peak 
HIIT: 50%–85% 
VO2peak 
C: NA
AEx: 55 minutes 
HIIT: 
   Continuous: 35 min-
utes (52 minutes at 
85%)
   HIIT: VO2peak followed 
by 2 minutes at 50% 
VO2peak
8 weeks
Okada et al. 
(2010) [23]
C: NR
AEx (continuous)+PRT:
AEx: aerobic dance, 
and stationary cycle 
ergometer
PRT: NR
Nil C: NA
AEx+PRT: 3–5/7 
(supervised)
C: NA
AEx+PRT: NR
C: NA
AEx+PRT: 
AEx: 55 minutes
PRT: 20 minutes 
Overall: 75 minutes
3 months
Ronnemaa  
et al. (1986) 
[31]
C: NA
AEx: walking, jogging, 
or skiing
Nil C: NA
AEx: 5–7/7
C: NA
AEx: 70% VO2peak
C: NA
AEx: 45 minutes
4 months
Tamura et al. 
(2005) [18]a 
D: Nil
AEx (continuous)+D: 
walking
Total mean ener-
gy intake of 27.9 
kcal/kg of ideal 
body weight for 
both groups for 
2 weeks
D: NA
AEx+D: 2–3/7 
(unsupervised)
D: NA
AEx+D: 50%–
60% VO2peak
D: NA
AEx+D: 30 minutes per 
session
2 weeks
Tan et al. 
(2012) [25]
C: maintain individual 
habits of physical activ-
ity
AEx (continuous)+PRT:
   AEx: walking, running 
   PRT: knee flexion, knee 
extension, hip abduc-
tion, hip adduction, 
and standing calf 
raise
Nil C: NA
AEx+PRT: 3/7 
(supervised)
C: NA
AEx+PRT: 
AEx: 55%–70% 
HRmax
PRT: 50%–70% 
1 RM
C: NA
AEx+PRT: 60 minutes
6 months
Tessier et al. 
(2000) [26]
C: NR
AEx (continuous) +PRT:
AEx: walking
PRT: strength/endur-
ance training of ma-
jor muscle groups
Nil C: NA
AEx+PRT: 3/7 
(supervised)
C: NA
AEx+PRT:
Initially: 35%–
59% HRmax
Week 4 onwards: 
60%–79% HRmax
C: NA
AEx+PRT: 60 minutes
16 weeks
Table 2. Continued 
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Author Mode Nutritional intervention Frequency Intensity
Session 
duration
Intervention 
duration
Wing et al. 
(1988) [32]
P+D: sham exercise 
(light calisthenics and 
flexibility exercises)
AEx+D: walking
Diet was de-
signed to pro-
duce approxi-
mately 1 kg/
week weight 
loss
P+D: 2/7  
(unsupervised)
AEx+D: 2/7  
(unsupervised)
P+D: low intensity
AEx+D: moderate 
intensity (speed 
and distance in-
creased until the 
individual able 
to walk 3 miles)
~60 minutes 10 weeks
Winnick et al. 
(2008) [27]
D: NA
AEx (continuous)+D: 
treadmill walking
Diet designed to 
maintain body 
weight close to 
baseline body 
weight
D: NA
AEx+D: 7/7
D: NA
AEx+D: 
Days 1–3, 5–7: 
70% VO2peak
Day 4: 60% pre-
dicted HRmax
D: NA
AEx+D: 2×25 minutes, 
10 minutes break be-
tween bouts
Day 4: 60 minutes
1 week
C, control; PRT, progressive resistance training; NA, not applicable; RM, repetition maximum; HIIT, high intensity interval training; NR, not 
reported; AEx, aerobic training; VO2peak, peak oxygen consumption; HRR, heart rate reserve; F, fish meal; D, diet; HRmax, maximal heart rate; P, 
placebo.
aConverted from standard error of mean to standard deviation.
Table 2. Continued 
events during the intervention [18,19,21,22,24,26,31,32], five 
studies did not report participants lost to follow-up [18-
21,32], and 10 studies did not report P values from statistical 
analysis [18-20,23,25-28,30,32]. The total score for method-
ological quality ranged from 16 to 24, out of a possible 29 
points, indicating generally moderate study quality. 
Study outcomes (ineligible for meta-analysis)
Table 3 shows the extracted outcome measures of all studies 
included. Two studies were excluded from the meta-analyses 
due to publication bias, as identified via visual inspection of 
funnel plot analyses and Egger’s test [17,18] (Y intercept, 
–5.287; standard error [SE], 0.895; 95% CI, –7.166 to –3.407; 
P<0.000). Upon exclusion, publication bias was improved (Y 
intercept, –2.942; SE, 0.816; 95% CI, –4.692 to –1.192; 
P=0.003). Three studies were excluded from the time effect 
subgroup analyses because they did not report timing of data 
collection postintervention [23,26,31]. These studies found 
regular exercise therapy to have a positive effect on glucose 
uptake as measured by clamp [23] and OGTT [26,31] (Okada 
et al. [23]: pre, 11.1±5.3 mmol/L, post, 9.7±4.2 mmol/L; 
Ronnemaa et al. [31]: pre, 19.7±4.9 mmol/L, post, 16.5±7.6 
mmol/L; Tessier et al. [26]: pre, 16.6±3.8, post, 15.3±3.1 area 
under the curve). Only one of these studies was found to have 
a statistically significant effect (P=0.04) [23]. 
Study outcomes (meta-analyses)
The meta-analysis was conducted with 14 studies involving a 
total of 411 adult participants. For the time effect subgroup 
analyses, nine studies reported the time of data collection 
from the last exercise bout. This included three studies which 
assessed insulin sensitivity less than 48 hours after the last ex-
ercise bout [20,27,29], three studies which assessed insulin 
sensitivity between 48 and 72 hours after exercise [19,25,32], 
and three studies which assessed insulin sensitivity more than 
72 hours after the last exercise bout [21,24,30]. All eligible 
studies had sufficient data for calculation of ES and 95% CIs 
for the purpose of meta-analysis. 
Pooled analysis: exercise versus control 
For the effect of exercise on insulin sensitivity, all 14 studies 
showed an ES favouring exercise therapy, ranging from –0.080 
to –1.428. Seven of these studies reached statistical signifi-
cance for a benefit of exercise versus control [19,21-23,27,30, 
32]. There was a significant pooled ES for the effect of exercise 
on insulin sensitivity via random effects model (ES, –0.588; 
95% CI, –0.816 to –0.359; P<0.000) (Fig. 1). Low (non-signif-
icant) heterogeneity among studies was observed (I 2 = 
16.723%, P=0.271). 
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Table 3. Outcomes of intervention studies for change in insulin sensitivity      
Author Mode, n Measure Time post-intervention, hr Pre, mean±SD Post, mean±SD Change score
Baldi et al.  
(2003) [20]a
C, 9
PRT, 9
OGTT 36–48 2-Hour glucose  
(mmol/L):
   C, 16.3±2.7
   PRT, 17.0±3.0
2-Hour glucose  
(mmol/L):
   C, 17.1±2.4
   PRT, 16.3±2.1
NR
Boudou et al. 
(2003) [21]
C, 8
AEx, 8
ITT 72–120 Constant rate of glucose 
disappearance (%/min):
   C, 1.95±1.00
   AEx, 2.15±0.65
Constant rate of glucose 
disappearance (%/min):
   C, 1.80±0.90
   AEx, 3.25±0.85
NR
Cuff et al.  
(2003) [19]a
C, 9
AEx, 9
AEx+PRT, 10
Clamp 48–72 Glucose infusion rate 
(mg · kg–1 · min–1):
   C, 2.29±1.38
   AEx, 2.78±1.47
   AEx+PRT, 2.36±1.04
Glucose infusion rate 
(mg · kg–1 · min–1):
   C, NR
   AEx, NR
   AEx+PRT, NR
Glucose infusion rate 
(mg · kg–1 · min–1):
   C, 0.07±0.84
   AEx, 0.55±1.08
   AEx+PRT, 
1.82±1.64
Dunstan et al. 
(1997) [17]b
C, 12
AEx, 11
F, 12
AEx+F, 14
OGTT >48 AUC glucose (mmol/ 
L–1 · 120 min–1):
   C, 1,810±340
   AEx, 1,916±480
   F, 1,787±465
   AEx+F, 2,004±500
NR AUC glucose (mmol/
L–1 · 120 min–1):
   C, 50±48.5
   AEx, –112.5±65.0
   F, 87.5±87.5
   F+AEx, –87.5±75.0 
Dunstan et al. 
(1998) [22]a
C, 10
PRT, 11
OGTT >48 NR NR AUC glucose (mmol/
L–1 · 120 min–1):
   C, 191±265
   PRT, –22±205 
Karstoft et al. 
(2013) [24]a
C, 8
AEx: 
  Continuous, 12
  Intermittent, 12
OGTT ≈96 2-Hour glucose  
(mmol/L): 
   C, 14.7±3.96
   AEx: 
     Continuous, 14.8±3.46
     Intermittent, 16.5±3.12
2-Hour glucose  
(mmol/L):
   C, 15.7±3.96
   AEx: 
     Continuous, 15.0±4.85 
     Intermittent, 15.4±4.50
NR
Ligtenberg et al. 
(1997) [28]
C, 28
AEx, 30
ITT <72 Glucose decline between 
4–14 minutes (%·min-1):
   C, 1.5±1
   AEx, 1.8±1.3
Glucose decline between 
4–14 minutes (%·min-1):
   C, 1.8±1.1
   AEx, 1.8±1.2
NR
Middlebrooke  
et al. (2006) [29]
C, 30
AEx, 22
ITT ≥24 ITT slope (mmol/ 
L–1 · min–1):
   C, –0.17±0.06
   AEx, –0.16±0.10
ITT slope (mmol/ 
L–1 · min–1):
   C, –0.17±0.06
   AEx, –0.17±0.07
NR
Mourier et al. 
(1997) [30]a
C, 11
AEx, 10
ITT 72–120 Constant rate of glucose 
disappearance (%·min-1):
   C, 1.86±0.96
   AEx, 2.28±0.73
Constant rate of glucose 
disappearance (%·min-1):
   C, 1.81±0.90
   AEx, 3.34±0.95
NR
Okada et al. 
(2010) [23]
C, 17
AEx+PRT, 21
SSPG NR SSPG (mmol/L):
   C, 14.1±3.4
   AEx+PRT, 11.1±5.3
SSPG (mmol/L):
   C, 9.7±4.6
   AEx+PRT: 9.7±4.2
NR
(Continued to the next page)
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Author Mode, n Measure Time post-intervention, hr Pre, mean±SD Post, mean±SD Change score
Ronnemaa et al. 
(1986) [31]
C, 12
AEx, 13
OGTT NR 2-Hour glucose  
(mmol/L):
   C, 19.6±4.1
   AEx, 19.7±4.9 
2-Hour glucose  
(mmol/L):
   C, 19.7±2.7 
   AEx, 16.5±7.6 
NR
Tamura et al. 
(2005) [18]a
D, 7
AEx+D, 7
Clamp >24 Steady-state glucose  
infusion rate  
(mg/kg/min):
   D, 6.12±2.46
   AEx+D, 5.26±0.87
Steady-state glucose  
infusion rate  
(mg/kg/min):
   C, 6.49±0.87
   AEx+D, 8.22±1.24
NR
Tan et al.  
(2012) [25]
C, 10
AEx+PRT, 15
OGTT 72 2-Hour glucose  
(mmol/L):
   C, 11.11±5.26
   AEx+PRT, 13.9±5.8
2-Hour glucose  
(mmol/L):
   C, 10.58±4.41
   AEx+PRT, 9.83±4.33
NR
Tessier et al. 
(2000) [26]
C, 20
AEx+PRT, 19
OGTT NR AUC glucose (mmol/L):
   C, 16.1±2.9
   AEx+PRT, 16.6±3.8
AUC glucose (mmol/L): 
   C, 15.9±3.0
   AEx+PRT, 15.3±3.1
NR
Wing et al.  
(1988) [32]
P+D, 12
AEx+D, 10
OGTT 72 Plasma glucose: 60 min-
utes (mmol/L):
   P+D, 14.6±0.9
   AEx+D, 14.3±1.2
Plasma glucose: 60 min-
utes (mmol/L):
   P+D, 11.3±1.2
   AEx+D, 10.9±1.3
NR
Winnick et al. 
(2008) [27]
D, 9
AEx+D, 9
Clamp <24 Glucose levels (mg/dL):
   D: 137.0±3.0 (low-
dose); 135.0±3.0 
(high-dose)
   AEx+D: 131.0±3.0 (low-
dose); 123.0±3.0 
(high-dose)
Glucose levels (mg/dL):
   D: 131.0±3.0 (low-
dose); 119.0±3.0 
(high-dose)
   AEx+D: 129.0±3.0 (low-
dose); 124.0±3.0 
(high-dose)
NR
SD, standard deviation; C, control; PRT, progressive resistance training; OGTT, oral glucose tolerance test; NR, not reported; AEx, aerobic 
training; ITT, insulin tolerance test; F, fish meal; AUC, area under the curve; SSPG, steady state plasma glucose; D, diet; P, placebo.
aConverted from standard error of mean to standard deviation, bData has been extrapolated from a graph.
Table 3. Continued 
Subanalysis: exercise versus control (<48 hours)
Fig. 2A shows the pooled ES for studies for the effect of exer-
cise on insulin sensitivity for <48 hours after the last exercise 
bout for the comparison of exercise and control. All three 
studies [20,27,29] showed an ES favouring exercise therapy, 
ranging from –1.333 to –0.155. One of these studies reached 
statistical significance of a benefit of exercise therapy (P= 
0.011) [27]. The pooled ES showed an improvement in insulin 
sensitivity in favour of exercise therapy (ES, –0.611; 95% CI, 
–1.295 to 0.073), although this did not reach statistical signifi-
cance (P=0.080). Low (non-significant) heterogeneity among 
studies was observed (I2=39.735%, P=0.103). 
Subanalysis: exercise versus control (48 to 72 hours)
Fig. 2B shows the pooled ES for the effect of exercise on insu-
lin sensitivity measured between 48 and 72 hours after the last 
exercise bout, for the comparison between exercise and con-
trol. There was a significant effect favouring exercise versus 
control (ES, –0.702; 95% CI, –1.392 to –0.012; P=0.046). All 
three studies [19,25,32] showed an ES favouring exercise ther-
apy, ranging from –1.321 to –0.080, with one of the studies 
showing a statistically significant improvement with exercise 
therapy [19]. Low (non-significant) heterogeneity among stud-
ies was observed (I2=45.258%, P=0.161).
Subanalysis: exercise versus control (>72 hours)
Fig. 2C displays the pooled ES for effect of exercise on insulin 
sensitivity measured more than 72 hours after the last exercise 
bout. A significant effect was observed favouring exercise ther-
apy (ES, –0.890; 95% CI, –1.675 to –0.105; P=0.026). All three 
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Fig. 1. Exercise versus control on insulin sensitivity. ES, effect size; CI, confidence interval.
Fig. 2. The effect of exercise on insulin sensitivity (A) <48 hours, (B) 48 to 72 hours, and (C) >72 hours after the last bout of ex-
ercise. ES, effect size; CI, confidence interval.
A
B
C
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studies [21,24,30] showed an ES favouring exercise therapy, 
ranging from –1.428 to –0.155. Two of the analysed studies 
reached statistical significance for the benefit of exercise on in-
sulin sensitivity [21,30]. Low (non-significant) heterogeneity 
among studies was observed (I2=49.0578%, P=0.140).
DISCUSSION 
Insulin resistance contributes significantly to the pathophysi-
ology of T2DM and increases the risk of heart disease and 
cancer. To our knowledge, this is the first systematic review 
with meta-analyses to examine the effect of regular exercise 
training on dynamic measures of insulin sensitivity in adults 
with T2DM. The results suggest that, when compared with a 
control intervention, regular exercise improves insulin sensi-
tivity in T2DM, and this may persist for more than 72 hours 
after the last exercise bout. 
It is generally accepted that regular exercise improves blood 
glucose control and enhances insulin sensitivity. A previous 
review and meta-analysis found that structured exercise train-
ing had a positive effect on HbA1c levels in adults with T2DM 
[3], when compared with control. As reported by Umpierre et 
al. [3], individuals who exercised ≥150 minutes per week 
showed a significant reduction in HbA1c (–0.89%) compared 
with those who participated in less than 150 minutes. Another 
systematic review and meta-analysis which investigated the 
effect of short-term exercise training (≤2 weeks) on glycaemic 
control, as measured with continuous glucose monitoring in 
T2DM, showed that exercise significantly reduced the daily 
time spent in hyperglycaemia (>10.0 mmol/L), but did not 
significantly change fasting blood glucose levels [34]. Statisti-
cal analysis of longer-term interventions could not be under-
taken in this study due to the heterogeneity in the timing of 
the continuous glucose monitoring measures. Thus whilst 
regular exercise improves HbA1c and appears to reduce hy-
perglycaemic incidence, this evidence is based on static mea-
sures of glycaemic control and not insulin sensitivity per se. 
HbA1c is predominately used as a tool for assessing long-term 
glycaemic control and is considered a representation of fast-
ing and postprandial glycaemia. Fasting glucose and insulin 
measures are more representative of glycaemic control and 
basal hyperinsulinemia; however, they do not necessarily re-
flect glycaemic response to insulin (insulin sensitivity/resis-
tance). 
Insulin resistance is marked by a decreased responsiveness 
to metabolic actions of insulin such as insulin-stimulated glu-
cose disposal and inhibition of hepatic glucose output [35]. 
Dynamic measures of insulin sensitivity mimic stimulated in-
sulin action, and reflect the peripheral insulin-mediated glu-
cose uptake, making these more sensitive measures than static 
techniques. Due to the major role of insulin resistance in 
T2DM, it is therefore important that dynamic measures are 
considered as assessment strategies to assess the efficacy of in-
terventions [35]. Our study highlights that currently there is a 
relative lack of evidence from exercise training interventions 
that have used outcome measures that are valid indices of in-
sulin sensitivity. 
Exercise is one of the first management strategies suggested 
by health professionals for glycaemic control in individuals 
with T2DM. The American College of Sports Medicine and 
American Diabetes Association joint position statement [1], 
and the American Heart Association [2] exercise guidelines 
recommend that individuals with T2DM should undertake 
exercise no less than every 48 hours to manage blood glucose 
levels and insulin resistance [1,2,7], and it has been suggested 
that the insulin sensitizing effect of exercise may be lost after 
48 to 72 hours [36,37]. However, it is generally acknowledged 
that the improvements seen in insulin sensitivity are not just 
attributable to acute exercise benefits (repeated regularly via 
training), but also chronic physiological changes (adapta-
tions) in glucose/insulin metabolism [6]. Namely, an acute 
bout of exercise has been shown to improve insulin sensitivity 
in both diabetic [37] and healthy [6,36,37] cohorts, but this ef-
fect is transient and diminishes during subsequent days with-
out training [6,36,37]. Yet, cross-sectional data show that en-
durance athletes; for instance, have a higher insulin respon-
siveness and greater peripheral glucose uptake than untrained 
healthy individuals even when the “last bout effect” is re-
moved [38,39]. Similarly, our results from the limited avail-
able data provide support for this at the whole body level by 
showing that regular exercise enhances insulin sensitivity in 
individuals with T2DM and the magnitude is greater than 
pre-training levels irrespective of whether there is a short 
(<48 hours) or longer (>72 hours) period of interspersed in-
activity. From a clinical perspective, this may imply that with 
adherence to chronic/regular exercise training, improved in-
sulin sensitivity can be maintained in people receiving exer-
cise for T2DM management, despite periods of inactivity. 
Despite the general consensus that regular exercise is effec-
tive for the management of insulin resistance in T2DM, our 
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review highlights a relative lack of data available from high 
quality studies (14 studies for the pooled analysis in our 
study) to support this. It does however provide phenotypic 
support that chronic regular exercise does have a persisting 
effect that appears to be diminished with acute exercise alone. 
It is still unclear what dosage and types of exercise result in 
persisting insulin sensitivity because different exercise modal-
ities, intensities, and durations were used in the eligible stud-
ies. Only nine studies reported the time point that insulin 
sensitivity measures were collected post-intervention. Of 
these nine studies, only three studies were eligible to be 
grouped into each time-point subanalyses. While this pro-
vides some evidence that chronic exercise has a persisting ef-
fect on insulin sensitivity, it is clear that future research needs 
to investigate this lasting effect. In the time-point subanalyses, 
only one study implemented PRT [20] and one study used 
combined exercise therapy (AEx and PRT) [25]. The Ameri-
can College of Sports Medicine and American Diabetes Asso-
ciation joint position statement [1] and the American Heart 
Association [2] exercise guidelines recommend that individu-
als with T2DM should partake in combined exercise therapy 
to manage blood glucose levels and insulin resistance. How-
ever, it is clear from our analyses that there is a lack of data 
available concerning the effect of combined exercise therapy 
on insulin sensitivity. It is important to note that the eligible 
studies adhered to the current exercise guidelines (mode, fre-
quency, duration, and intensity) for T2DM glycaemic control 
[1,2]. Our study reinforces the importance of regular exercise, 
as suggested by the current exercise guidelines, and its en-
hancement of insulin sensitivity. The exercise-induced in-
crease in insulin sensitivity is believed to reflect adaptations in 
muscle insulin signaling [40,41], GLUT4 protein expression, 
content and action [6,7] and associated improvement in insu-
lin-stimulated glucose disposal and glycogen synthesis 
[40,41]. This is accompanied and influenced by enhanced in-
tramyocellular oxidative enzyme capacity and possibly chang-
es in muscle architecture from fast-type to slow-type fibres 
[42,43]. Our analysis supports evidence showing that regular 
exercise training can produce persistent physiological adapta-
tions that improve insulin sensitivity, which may not just be as 
a result of transient physiologic responses.
There are some limitations of the current study that should 
be considered when interpreting the results. Only nine studies 
met the inclusion criteria and were eligible for the conducted 
subanalyses, and these were limited by small sample sizes [19-
21,24,25,27,29,30,32]. Given the potential efficacy of exercise 
and the generally positive findings of existing studies, there is 
a clear need for further research examining the effectiveness 
of exercise interventions on insulin sensitivity, using dynamic 
measurements. Furthermore, differences in exercise prescrip-
tion (intensity, duration, frequency, and intervention length) 
contributed to heterogeneity in the available research. Simi-
larly, the differences in dynamic measurement techniques 
could further contribute to heterogeneity (clamp, OGTT, and 
ITT). Evaluating the quality of studies using the Down and 
Black scale found all of the analyzed studies to be of moderate 
quality. This may have also contributed to the heterogeneity of 
the results. There has been a limited investigation of the effect 
of interval aerobic exercise training on insulin sensitivity in 
T2DM, despite its known benefit in improving glucose uptake 
in healthy populations. Further research needs to be conduct-
ed to investigate optimal exercise prescription and the treat-
ment of insulin sensitivity in T2DM.
This systematic review with meta-analyses provides useful 
information for the clinical application of exercise in the man-
agement of T2DM. The results show clear evidence for the ef-
fectiveness of exercise therapy for improving insulin sensitivi-
ty for at least 72 hours after the final bout. However, it cannot 
be determined whether exercise training frequency may be 
reduced to this extent, or if more frequent training, as per-
formed in the included studies, is required for the insulin sen-
sitizing effect to become apparent. The results have implica-
tions for clinicians in regards to advice pertaining to unex-
pected breaks from exercise training: a trained individual with 
T2DM may have a 24- to 72-hour gap in between training 
sessions due to injury, personal or family reasons. Our results 
indicate that within this time frame the insulin sensitizing ef-
fect is not lost; thus, there may be no increased risk of hyper-
glycemia or need to adjust medication within this period. 
CONCLUSIONS
This is the first study to collectively pool data assessing the ef-
fect of regular exercise on dynamic measures of insulin sensi-
tivity in people with T2DM. Our study found that regular ex-
ercise has a significant benefit on insulin sensitivity, which 
may persist for 72 hours or longer after the last training bout. 
While current exercise guidelines for T2DM highlight the im-
portance of avoiding consecutive days of physical inactivity, 
there is very limited data from high quality RCTs to corrobo-
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rate this. Our findings suggest that short periods of inactivity 
(e.g., 72 hours) may not result in a loss of insulin sensitivity, 
and this may reflect chronic adaptations to the underlying 
pathophysiology. Therefore, clinicians should reinforce the 
importance of regular exercise to manage insulin sensitivity as 
these chronic benefits may ensure that short-term periods of 
inactivity will not negate the therapeutic effect from generally 
regular exercise participation. This study also highlights the 
relative lack of evidence investigating the effect of insulin sen-
sitivity after prolonged physical inactivity (beyond 72 hours) 
making it difficult to conclude on the lasting insulin sensitiz-
ing effect. 
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